Viela Bio Investigative Siite

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease	Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder	Active, not recruiting	Phase 3	2025-12-11		NCT04540497

Clinical trials